BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 33551224)

  • 1. Functional Role of Novel Indomethacin Derivatives for the Treatment of Hepatocellular Carcinoma Through Inhibition of Platelet-Derived Growth Factor.
    Patel S; Nanavati P; Sharma J; Chavda V; Savjani J
    Arch Med Res; 2021 Jul; 52(5):483-493. PubMed ID: 33551224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer Potential of Mefenamic Acid Derivatives with Platelet-Derived Growth Factor Inhibitory Property.
    Patel SS; Tripathi R; Chavda VK; Savjani JK
    Anticancer Agents Med Chem; 2020; 20(8):998-1008. PubMed ID: 32294047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nimbolide inhibits tumor growth by restoring hepatic tight junction protein expression and reduced inflammation in an experimental hepatocarcinogenesis.
    Ram AK; Vairappan B; Srinivas BH
    World J Gastroenterol; 2020 Dec; 26(45):7131-7152. PubMed ID: 33362373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of Rumex vesicarius as anticancer remedy against hepatocellular carcinoma: a proposal-based on experimental animal studies.
    Shahat AA; Alsaid MS; Kotob SE; Ahmed HH
    Asian Pac J Cancer Prev; 2015; 16(10):4303-10. PubMed ID: 26028090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
    Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artesunate obliterates experimental hepatocellular carcinoma in rats through suppression of IL-6-JAK-STAT signalling.
    Ilamathi M; Prabu PC; Ayyappa KA; Sivaramakrishnan V
    Biomed Pharmacother; 2016 Aug; 82():72-9. PubMed ID: 27470341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-derived growth factor receptor α in hepatocellular carcinoma is a prognostic marker independent of underlying liver cirrhosis.
    Yu JH; Kim JM; Kim JK; Choi SJ; Lee KS; Lee JW; Chang HY; Lee JI
    Oncotarget; 2017 Jun; 8(24):39534-39546. PubMed ID: 28465473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of p53-R249S on the Suppression of Hepatocellular Carcinoma Cells Survival Induced by Podophyllum Derivatives.
    Chen H; Zhang M; Wang Z; Li L; Li Q; Wang H
    Anticancer Agents Med Chem; 2020; 20(7):865-874. PubMed ID: 32067620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of chemopreventive effect of Fumaria indica against N-nitrosodiethylamine and CCl4-induced hepatocellular carcinoma in Wistar rats.
    Hussain T; Siddiqui HH; Fareed S; Vijayakumar M; Rao CV
    Asian Pac J Trop Med; 2012 Aug; 5(8):623-9. PubMed ID: 22840450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TSU-68 ameliorates hepatocellular carcinoma growth by inhibiting microenvironmental platelet-derived growth factor signaling.
    Hara Y; Yamashita T; Oishi N; Nio K; Hayashi T; Nomura Y; Yoshida M; Hayashi T; Hashiba T; Asahina Y; Kondo M; Okada H; Sunagozaka H; Honda M; Kaneko S
    Anticancer Res; 2015 Mar; 35(3):1423-31. PubMed ID: 25750293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro.
    Nass N; Streit S; Wybranski C; Jürgens J; Brauner J; Schulz N; Powerski M; Ricke J; Kalinski T; Dudeck O; Seidensticker M
    Anticancer Res; 2017 Jan; 37(1):87-93. PubMed ID: 28011478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel 2-phenyloxypyrimidine derivative induces apoptosis and autophagy via inhibiting PI3K pathway and activating MAPK/ERK signaling in hepatocellular carcinoma cells.
    Wang J; Sun P; Chen Y; Yao H; Wang S
    Sci Rep; 2018 Jul; 8(1):10923. PubMed ID: 30026540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Dihydropyrimidinone-Derived Selenoesters as Potential Cytotoxic Agents to Human Hepatocellular Carcinoma: Molecular Docking and DNA Fragmentation.
    Benassi JC; Barbosa FAR; Grinevicius VMAS; Ourique F; Coelho D; Felipe KB; Braga AL; Filho DW; Pedrosa RC
    Anticancer Agents Med Chem; 2021; 21(6):703-715. PubMed ID: 32723262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of platelet-derived growth factor receptor alpha promotes tumor progression and indicates poor prognosis in hepatocellular carcinoma.
    Wei T; Zhang LN; Lv Y; Ma XY; Zhi L; Liu C; Ma F; Zhang XF
    Oncotarget; 2014 Nov; 5(21):10307-17. PubMed ID: 25333264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic effect of chromanone derivative, hyrtiosone A from marine demosponge Hyrtios erectus in hepatocellular carcinoma HepG2 cells.
    Chakraborty K; Francis P
    Bioorg Chem; 2021 Sep; 114():105119. PubMed ID: 34252861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morus nigra L. extract prolongs survival of rats with hepatocellular carcinoma.
    Hooshmand S; Mahdinezhad MR; Taraz Jamshidi S; Soukhtanloo M; Mirzavi F; Iranshahi M; Hasanpour M; Ghorbani A
    Phytother Res; 2021 Jun; 35(6):3365-3376. PubMed ID: 33624311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-derived growth factor receptor-alpha: a novel therapeutic target in human hepatocellular cancer.
    Stock P; Monga D; Tan X; Micsenyi A; Loizos N; Monga SP
    Mol Cancer Ther; 2007 Jul; 6(7):1932-41. PubMed ID: 17604334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin: a unique antioxidant offers a multimechanistic approach for management of hepatocellular carcinoma in rat model.
    Ahmed HH; Shousha WG; Shalby AB; El-Mezayen HA; Ismaiel NN; Mahmoud NS
    Tumour Biol; 2015 Mar; 36(3):1667-78. PubMed ID: 25371072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting stromal cells for the treatment of platelet-derived growth factor C-induced hepatocellular carcinogenesis.
    Campbell JS; Johnson MM; Bauer RL; Hudkins KL; Gilbertson DG; Riehle KJ; Yeh MM; Alpers CE; Fausto N
    Differentiation; 2007 Nov; 75(9):843-52. PubMed ID: 17999742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of metallothionein expression in human and murine hepatocellular tumors: association with the tumor-necrotizing and antineoplastic effects of cadmium in mice.
    Waalkes MP; Diwan BA; Rehm S; Ward JM; Moussa M; Cherian MG; Goyer RA
    J Pharmacol Exp Ther; 1996 May; 277(2):1026-33. PubMed ID: 8627513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.